|
|
| Research article summary (published 27 Dec 2007): |
|
Free Full Text! See links below |
Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
Full Abstract
Dok-7 is a cytoplasmic activator of muscle-specific receptor-tyrosine kinase (MuSK). Both Dok-7 and MuSK are required for neuromuscular synaptogenesis. Mutations in DOK7 underlie a congenital myasthenic syndrome (CMS) associated with small and simplified neuromuscular synapses likely due to impaired Dok-7/MuSK signaling. The overwhelming majority of patients with DOK7 CMS have at least one allele with a frameshift mutation that causes a truncation in the COOH-terminal region of Dok-7 and affects MuSK activation. Dok-7 has pleckstrin homology (PH) and phosphotyrosine binding (PTB) domains in the NH2-terminal moiety, both of which are indispensable for MuSK activation in myotubes, but little is known about additional functional elements. Here, we identify a chromosome region maintenance 1-dependent nuclear export signal (NES) in the COOH-terminal moiety and demonstrate that the NES-mediated cytoplasmic location of Dok-7 is essential for regulating the interaction with MuSK in myotubes. The NH2-terminal PH domain is responsible for the nuclear import of Dok-7. We also show that the Src homology 2 target motifs in the COOH-terminal moiety of Dok-7 are active and crucial for MuSK activation in myotubes. In addition, CMS-associated missense mutations found in the PH or PTB domain inactivate Dok-7. Together, these findings demonstrate that, in addition to the NH2-terminal PH and PTB domains, the COOH-terminal NES and Src homology 2 target motifs play key roles in Dok-7/MuSK signaling for neuromuscular synaptogenesis. Ablation or disruption of these functional elements in Dok-7 probably underlies the neuromuscular junction synaptopathy observed in DOK7 CMS.
Author information
Author/s: Hamuro, Johko (J); Higuchi, Osamu (O); Okada, Kumiko (K); Ueno, Makiko (M); Iemura, Shun-ichiro (S); Natsume, Tohru (T); Spearman, Hayley (H); Beeson, David (D); Yamanashi, Yuji (Y);
Affiliation: Department of Cell Regulation, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Yushima, Tokyo 113-8510, Japan.
Grants: (Agency:Medical Research Council)
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: The Journal of biological chemistry (J Biol Chem), published in United States. (Language: eng)
Reference: 2008-Feb; vol 283 (issue 9) : pp 5518-24
Dates: Created 2008/02/25; Completed 2008/04/15; Revised 2008/11/21;
PMID: 18165682, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- A novel pathway for MuSK to induce key genes in neuromuscular synapse formation.
17 May 2003 - Building the vertebrate neuromuscular synapse.
29 Nov 2002 - Increased ratio of rapsyn to ACh receptor stabilizes postsynaptic receptors at the mouse neuromuscular synapse.
16 Nov 2004 - Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis.
28 Feb 2004 - LRP4 serves as a coreceptor of agrin.
21 Oct 2008 - Congenital canine myasthenia gravis: II. Acetylcholine receptor metabolism.
30 Oct 1984 - Casein kinase 2-dependent serine phosphorylation of MuSK regulates acetylcholine receptor aggregation at the neuromuscular junction.
29 Jun 2006 - Congenital myasthenic syndromes and the formation of the neuromuscular junction.
30 Dec 2007 - Macrophage infiltration at the neuromuscular junction does not contribute to AChR loss and age-related resistance to EAMG.
29 Apr 1997 - [The neuromuscular junction in myasthenia. Human and experimental morphological data (author's transl)]
28 Feb 1980
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.